Login / Signup

Long-Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER-OLE Study.

Ahmad MasriSteven J LesterJohn C StendahlSheila M HegdeAmy J SehnertGanesh BalaratnamAshish ShahShawna FoxAndrew Wang
Published in: Journal of the American Heart Association (2024)
URL: https://www.clinicaltrials.gov; Unique identifier: NCT03496168.
Keyphrases
  • hypertrophic cardiomyopathy
  • left ventricular
  • heart failure
  • atrial fibrillation